Gabapentin Capsule
Product Images NDC 72789-289

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72789-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789289)

Image (72789289)
This is a medication warning label for Gabapentin, which is commonly used to treat seizures and nerve pain. The label warns that the medication may cause drowsiness and should be avoided with alcohol. It may also impair driving vehicles and vessels. It is important not to take antacids simultaneously. The label includes information on dosage and storage, alongside a warning to keep the medication out of reach of children. The medication is available in 100 mg capsules and should be taken as advised by a doctor. The label also includes details about FDA reporting of side effects. The available stock has an expiration date of 08/2025.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
This is a chart showing different pain scores for different treatments over the course of multiple weeks. The treatments include a placebo and gabapentin at a dose of 3600 mg/day, administered in either a fixed or titrated dose period. The main focus appears to be on the mean pain score, which is indicated to be 0 at the start of the trial.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This is a graph representing the 3-week dose titration period for a study involving placebo and Gabapentin at different doses (1800 mg/day and 2400 mg/day). The y-axis represents the mean pain score and the x-axis represents the weeks of the study, from baseline to week 7.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.